Christopher Groux is an editor, writer and accessibility advocate. Before joining the Forbes Health team, he covered Accessibility at Reviewed and gaming at Inverse and Newsweek. When he’s not ...
The FDA approves the Allurion balloon for weight loss, which is swallowed and doesn't require a procedure for removal. Doctors explain how it works.
Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others? The question was explored in a new study published this month in The New ...
Alternatives to Ozempic for Weight Loss This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Ozempic is an ...
Early weight loss ≥ 2% or ≥ 3% by 4 weeks in structured weight-loss programs is significantly associated with achieving ≥ 5% or ≥ 10% total weight loss, respectively, by 16 weeks in adults with class ...
A new oral version of Wegovy has been FDA-approved, offering a more affordable and accessible option to injectable GLP-1 medications that have transformed weight loss treatment for millions.
An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost breakdown, weekly provider check-in structure, clinical claims analysis, a ...
Physician supervised weight loss takes a different approach. It includes regular lab work to monitor metabolic markers, adjustments based on individual patient response, and integ ...
Ozempic Alternatives for Weight Loss: What Are Your Options? Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss — when a drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results